Fundraising Fox

Aeromics, LLC

New Haven, US · Founded 2016 · Delaware corporation · 2 known investors

aeromics.com ↗

Aeromics is a clinical-stage biopharmaceutical company developing AER-271, an aquaporin-4 inhibitor to prevent cerebral edema (brain swelling) in severe acute ischemic stroke patients. The therapy targets molecular water channels to improve survival and recovery outcomes while reducing the need for invasive surgical interventions.

BiotechMedical Devices

Founders & leadership

DP
Dr. PelletierFounder
DB
Dr. BoronFounder
FJ
Frederick JonesDirector
PM
Paul McGuirkExecutive Officer
WB
Walter BoronExecutive Officer, Director
GF
George FarrExecutive Officer
JF
John FosterDirector
PL
Peter LongoDirector

Investors · 2

Connecticut Innovations✓ verifiedNew Haven · $500K – $2M
Broadview VenturesBoston

Reported raises · per SEC filings

Form D private placements
▶$9.4MraisedDec 2018 · 57 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Peter LongoDirector
  • Jeffrey DraimeDirector
  • Mark DayDirector
  • Thomas ZindrickDirector
  • Christine AntalikExecutive Officer
  • Marc F. PelletierExecutive Officer, Director
Offering amount
$11.1M
Amount sold
$9.4M
First sale
Oct 2017
Incorporated
Corporation, Delaware, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.5MraisedJul 2017 · 11 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Walter BoronExecutive Officer, Director
  • Frederick JonesDirector
  • Peter LongoDirector
  • Paul SchlatherDirector
  • Paul McGuirkExecutive Officer
  • George FarrExecutive Officer
  • Jeff DraimeDirector
  • John FosterDirector
  • Marc F. PelletierExecutive Officer, Director
Offering amount
$1.8M
Amount sold
$1.5M
First sale
Mar 2017
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.9MraisedApr 2016 · 5 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Frederick JonesDirector
  • Paul McGuirkExecutive Officer
  • Peter LongoDirector
  • Walter BoronExecutive Officer, Director
  • George FarrExecutive Officer
  • Marc F. PelletierExecutive Officer, Director
  • John FosterDirector
Offering amount
$3M
Amount sold
$1.9M
First sale
Apr 2016
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.